Chi Limin, Li Mengyan, Zhou Hanxing, Hung Mien-Chie, Wang Wei-Jan, Wang Bo, Sun Xian
Department of Oncology, The Seventh Affiliated Hospital, Sun Yat-Sen University Shenzhen, Guangdong, P. R. China.
Graduate Institute of Biomedical Sciences, Institute of Biochemistry and Molecular Biology, China Medical University Taichung 406, Taiwan.
Am J Cancer Res. 2025 Mar 15;15(3):855-875. doi: 10.62347/NJCQ2464. eCollection 2025.
The relationship between interstitial lung disease (ILD) and lung cancer in nonsmokers (LCINS) has garnered increasing interest. However, the causal associations and underlying pathogenesis between ILD and LCINS remain poorly understood.
This research utilized a bidirectional two-sample Mendelian randomization (MR) method, utilizing forward MR analysis to assess the causal impact of ILD on LCINS and reverse MR analysis to evaluate the causal effect of LCINS on ILD. Additionally, transcriptome data and bioinformatics analyses were used to explore the associations between ILD and LCINS. An ILD-related gene signature (ILD risk score) was identified to examine its influence on the hallmark signaling pathways and the immune microenvironment in LCINS.
The study revealed a significant causal relationship between ILD and LCINS, with ILD increasing the risk of lung cancer in nonsmoking European populations. We developed a 5-gene risk model, which includes CD1A, CDH3, KRT6B, MMP1, and MMP10, via least absolute shrinkage and selection operator (LASSO) regression. The ILD risk score independently influences the prognosis of nonsmoking patients with lung cancer, and these five genes are also significantly associated with overall survival (OS) rates. Patients in the high-ILD risk subgroup exhibited significantly poorer survival rates. A highly accurate nomogram was developed to increase the clinical applicability of the ILD risk score. Additionally, the ILD risk scores were significantly correlated with hallmark signaling pathways and immune cell infiltration.
This study suggested that ILD may have a positive causal effect on LCINS, with the ILD risk score serving as an effective predictor of the prognoses in LCINS patients. It is associated with tumor proliferation and the activation of metabolism-related signaling pathways. These findings also indicate that ILD may contribute to the occurrence and progression of LCINS through its influence on immune cell infiltration.
间质性肺疾病(ILD)与非吸烟者肺癌(LCINS)之间的关系已引起越来越多的关注。然而,ILD与LCINS之间的因果关联和潜在发病机制仍知之甚少。
本研究采用双向双样本孟德尔随机化(MR)方法,利用正向MR分析评估ILD对LCINS的因果影响,反向MR分析评估LCINS对ILD的因果效应。此外,利用转录组数据和生物信息学分析来探索ILD与LCINS之间的关联。确定了一个与ILD相关的基因特征(ILD风险评分),以研究其对LCINS中标志性信号通路和免疫微环境的影响。
该研究揭示了ILD与LCINS之间存在显著的因果关系,ILD增加了非吸烟欧洲人群患肺癌的风险。我们通过最小绝对收缩和选择算子(LASSO)回归开发了一个包含CD1A、CDH3、KRT6B、MMP1和MMP10的5基因风险模型。ILD风险评分独立影响非吸烟肺癌患者的预后,这五个基因也与总生存率(OS)显著相关。高ILD风险亚组的患者生存率显著较差。开发了一个高度准确的列线图以提高ILD风险评分的临床适用性。此外,ILD风险评分与标志性信号通路和免疫细胞浸润显著相关。
本研究表明ILD可能对LCINS有正向因果效应,ILD风险评分可作为LCINS患者预后的有效预测指标。它与肿瘤增殖和代谢相关信号通路的激活有关。这些发现还表明,ILD可能通过影响免疫细胞浸润促进LCINS的发生和发展。